REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Seres Laboratorio Farmaceutico S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Seres Laboratorio Farmaceutico S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Seres Laboratorio Farmaceutico S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on April 02, 1998. 5 (2024) employees currently work for Seres Laboratorio Farmaceutico S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 6.93% in 2024. Over the same period, its total assets grew by 6.5%.

Headquarters
Lot Brisas del Santay S8
Guayaquil; Guayas;

Contact Details: Purchase the Seres Laboratorio Farmaceutico S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Seres Laboratorio Farmaceutico S.A. report to view the information.
Registered Capital:
Purchase the Seres Laboratorio Farmaceutico S.A. report to view the information.
Financial Auditors:
Purchase the Seres Laboratorio Farmaceutico S.A. report to view the information.
Incorporation Date:
April 02, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
48.24%
Purchase this report to view the information.
48.24%
Purchase this report to view the information.
3.52%
Company Performance
Financial values in the chart are available after Seres Laboratorio Farmaceutico S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
6.93%▲
Total operating revenue
6.93%▲
Operating profit (EBIT)
18.73%▲
EBITDA
11.3%▲
Net Profit (Loss) for the Period
56186.44%▲
Total assets
6.5%▲
Total equity
2.14%▲
Operating Profit Margin (ROS)
0.72%▲
Debt to Equity Ratio
-3.52%▼
Quick Ratio
-0.43%▼
Cash Ratio
-0.14%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo